Pharma Mar SA's market cap is currently ―. The company's EPS TTM is $0.122; its P/E ratio is 323.36; and it has a dividend yield of 1.38%. Pharma Mar SA is scheduled to report earnings on July 25, 2024, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	€ 54.94M	-	€ 48.25M	€ 53.19M	€ 85.89M
Gross Profit	€ 48.71M	-	€ 44.61M	€ 49.40M	€ 80.70M
EBIT	€ 4.91M	€ -716.55K	€ 7.13M	€ 22.14M	€ 49.58M
EBITDA	€ 6.97M	-	€ 8.70M	€ 23.66M	€ 51.03M
Net Income Common Stockholders	€ 5.98M	-	€ 12.95M	€ 21.98M	€ 38.16M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	€ 182.42M	€ 0.00	€ 196.70M	€ 221.59M	€ 201.88M
Total Assets	€ 393.26M	-	€ 390.77M	€ 378.03M	€ 368.39M
Total Debt	€ 42.63M	€ 0.00	€ 44.62M	€ 47.70M	€ 49.33M
Net Debt	€ -139.79M	€ 0.00	€ -152.08M	€ -173.89M	€ -152.55M
Total Liabilities	€ 170.30M	-	€ 183.84M	€ 176.23M	€ 190.47M
Stockholders Equity	€ 222.96M	€ 0.00	€ 206.94M	€ 201.80M	€ 177.92M
Cash Flow	-
Free Cash Flow	€ -8.30M	€ -1.10M	€ -1.34M	€ 35.31M	€ -1.67M
Operating Cash Flow	€ -2.07M	-	€ -571.00K	€ 35.82M	€ 897.00K
Investing Cash Flow	€ 19.34M	-	€ -9.73M	€ 2.58M	€ -10.46M
Financing Cash Flow	€ 3.16M	-	€ 836.00K	€ -752.00K	€ -9.21M

Currency in EUR

Pharma Mar SA Earnings and Revenue History

Income Statement >

Pharma Mar SA Debt to Assets

Balance Sheet >

Pharma Mar SA Cash Flow

Cash Flow >

Pharma Mar SA Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing